CD34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis-Reference-Cited by-同舟云学术

CD34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis

Published:2014-10 Issue:10 Volume:29 Page:1830-1838
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Nakamura Toru¹²,Torimura Takuji²,Iwamoto Hideki¹²,Kurogi Jyunichi¹³,Inoue Hiroto¹,Hori Yukie⁴,Sumie Shuji¹,Fukushima Nobuyoshi¹,Sakata Masahiro¹²,Koga Hironori¹²,Abe Mitsuhiko¹²,Ikezono Yu¹²,Hashimoto Osamu¹²,Ueno Takato²³,Oho Kazuhiko⁵,Okamura Takashi⁶,Okuda Seiya⁷,Kawamoto Atsuhiko⁸,Ii Masaaki⁹,Asahara Takayuki⁸¹⁰,Sata Michio¹

Affiliation:

1. Division of Gastroenterology; Department of Medicine; Kurume University School of Medicine; Kurume Japan

2. Liver Cancer Division; Research Center for Innovative Cancer Therapy; Kurume University; Kurume Japan

3. Department of Gastroenterology; Asakura Medical Association Hospital; Asakura Japan

4. Department of Laboratory Medicine; Kurume University Hospital; Kurume Japan

5. Department of Gastroenterology; Yanagawa Hospital; Yanagawa Japan

6. Division of Hematology and Oncology; Department of Medicine; Kurume University School of Medicine; Kurume Japan

7. Division of Nephrology; Department of Medicine; Kurume University School of Medicine; Kurume Japan

8. Group of Vascular Regeneration Research; Institute of Biomedical Research and Innovation; Kobe Japan

9. Department of Pharmacology; Faculty of Medicine; Osaka Medical College; Takatsuki Japan

10. Department of Regenerative Medicine Science; Tokai University School of Medicine; Isehara Japan

Funder

Ministry of Education, Science, Sports, and Culture of Japan

Ishibashi Foundation for the Promotion of Science

Ministry of Health, Labour and Welfare of Japan

Medical care education research foundation

Kaibara Morikazu Medical Science Promotion Foundation

Terumo Life Science Foundation

Clinical Medicine Promotion Foundation

Viral Hepatitis Research Foundation of Japan

MEXT-Supported Program for the Strategic Research Foundation at Private Universities

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12622/fullpdf

Reference35 articles.

1. Liver cirrhosis;Schuppan;Lancet,2008

2. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies;D'Amico;J. Hepatol.,2006

4. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan;Makuuchi;Hepatol. Res.,2008

5. Bone marrow-derived stem cells in liver repair: 10 years down the line;Gilchrist;Liver Transpl.,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial;Regenerative Therapy;2024-12

2. Efficacy of Granulocyte Colony-Stimulating Factor in Acute on Chronic Liver Failure: A Systematic Review and Survival Meta-Analysis;Journal of Clinical Medicine;2023-10-16

3. Therapeutic Angiogenesis Using Autologous CD34-Positive Cells for Vascular Diseases;Annals of Vascular Diseases;2022-12-25

4. Pre-Clinical Proof of Concept: Intra-Carotid Injection of Autologous CD34-Positive Cells for Chronic Ischemic Stroke;Frontiers in Medicine;2022-03-11

5. Acute Kidney Injury Successfully Treated with Autologous Granulocyte Colony-Stimulating Factor-mobilized Peripheral Blood CD34-Positive Cell Transplantation: A first-in-Human Report;Stem Cells Translational Medicine;2021-05-06